Multiple Myeloma: Risk Adapted Use of Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplantation is Effective and Cost Efficient-Reference-Cited by-同舟云学术

Multiple Myeloma: Risk Adapted Use of Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplantation is Effective and Cost Efficient

Published:2022-01 Issue:1 Volume:22 Page:44-51
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Prakash Vadlamani Surya,Malik Prabhat Singh,Sahoo Ranjit Kumar,Pramanik Raja,Choudhary Priyanshu,Varshney Ankur Nandan,Kumar Lalit

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference18 articles.

1. Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations;Giralt;Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant,2014

2. Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation;Mohty;Bone Marrow Transplant,2014

3. Comparison of the efficiency, safety, and survival outcomes in two stem cell mobilization regimens with cyclophosphamide plus G-CSF or G-CSF alone in multiple myeloma: a meta-analysis;Wang;Ann Hematol,2021

4. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma;DiPersio;Blood,2009

5. Plerixafor Plus Granulocyte Colony-Stimulating Factor versus Placebo Plus Granulocyte Colony-Stimulating Factor for Mobilization of CD34+ Hematopoietic Stem Cells in Patients with Multiple Myeloma and Low Peripheral Blood CD34+ Cell Count: Results of a Subset Analysis of a Randomized Trial

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal approach to stem cell mobilization in transplant-eligible multiple myeloma patients;Journal of Cancer Metastasis and Treatment;2024-05-27

2. Historical Perspective of High-Dose Therapy Followed by Autologous Stem Cell Transplantation in Multiple Myeloma;Acta Haematologica;2024-05-06

3. Is There Still a Role for Stem Cell Transplantation in Multiple Myeloma?;Hematology/Oncology Clinics of North America;2023-12

4. Poor Mobilizers in Lymphoma but Not Myeloma Patients Had Significantly Poorer Progression-Free Survival after Autologous Stem Cell Transplantation: Results of a Large Retrospective, Single-Center Observational Study;Cancers;2023-01-18

5. Impact of Mobilization Strategies on Peripheral Blood Stem Cell Collection Efficiency and Product Quality: A Retrospective Single-Center Study;Cancers;2022-12-19